Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Revolution Medicines Inc shares valued at $1,407,586 were sold by GOLDSMITH MARK A on Nov 18 ’25. At $70.38 per share, GOLDSMITH MARK A sold 20,000 shares. The insider’s holdings dropped to 247,863 shares worth approximately $17.32 million following the completion of this transaction.
Also, Cislini Jeff sold 13,388 shares, netting a total of over 939,008 in proceeds. Following the sale of shares at $70.14 each, the insider now holds 50,425 shares.
Before that, MARK A GOLDSMITH had added 20,000 shares to its account. In a trade valued at $1,382,800, the Director bought Revolution Medicines Inc shares for $69.14 each.
As published in their initiating research note from Wolfe Research on November 18, 2025, Revolution Medicines Inc [RVMD] has been an Outperform and the price target has been revised to $75. Analysts at RBC Capital Mkts started covering the stock with ‘”an Outperform”‘ outlook in a report released in early November. As of October 21, 2025, Mizuho has initiated its “an Outperform” rating for RVMD.
Analyzing RVMD Stock Performance
On last trading session, Revolution Medicines Inc [NASDAQ: RVMD] plunged -0.92% to $69.88. The stock’s lowest price that day was $69.75, but it reached a high of $72.72 in the same session. During the last five days, there has been a surge of approximately 8.54%. Over the course of the year, Revolution Medicines Inc shares have jumped approximately 28.83%. Shares of the company reached a 52-week high of $72.72 on 11/20/25 and a 52-week low of $29.17 on 04/07/25.
Support And Resistance Levels for Revolution Medicines Inc (RVMD)
According to the 24-hour chart, there is a support level at 68.85, which, if violated, would cause prices to drop to 67.81. In the upper region, resistance lies at 71.82. The next price resistance is at 73.75. RSI (Relative Strength Index) is 80.71 on the 14-day chart, showing overbought technical sentiment.
Is Revolution Medicines Inc subject to short interest?
Stocks of Revolution Medicines Inc saw a sharp rise in short interest on 2025-10-31 jumping by 54166.0 shares to 18.02 million. Data from Yahoo Finance shows that the short interest on 2025-09-30 was 17.97 million shares. A jump of 0.3% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 8.47 of the overall float, the days-to-cover ratio (short ratio) jumped to 8.47.
Which companies own the most shares of Revolution Medicines Inc (RVMD)?
In terms of Revolution Medicines Inc share price expectations, FactSet research, analysts set an average price target of 78.5 in the next 12 months, up nearly 11.3% from the previous closing price of $70.53. Analysts anticipate Revolution Medicines Inc stock to reach 99 by 2025, with the lowest price target being 75. In spite of this, 13 analysts ranked Revolution Medicines Inc stock as Buy at the end of 2025. On September 12, 2025, Raymond James assigned a price target of “a Strong buy” to the stock and resumed coverage with a $72.
